International Vaccine Institute strategic demand forecasting; and Sabin – communications and advocacy. Besides leading the consortium, IVI generated evidence for decision-making such as disease burden, country vaccine introduction cases and a global investment case. From 2010 to 2016, DVI operated in Brazil, Burkina Faso, Cambodia, Colombia, Gabon, India, Kenya, Thailand, and Vietnam. From 2013-2015, with funding from Germany’s Federal Ministry of Education & Research (BMBF), IVI continued support for preclinical development of dengue vaccines by Brazil’s Butantan Institute and Vietnam’s VaBiotech. After the 2016 licensure of Sanofi Pasteur’s Dengvaxia vaccine, the DVI project came to a close and its IVI staff transitioned to
Oswaldo Cruz Cruz. As a child, he moved to Rio de Janeiro with his family. At the age of 15 he started to study at the Faculty of Medicine of Rio de Janeiro and in 1892 he graduated as medical doctor with a thesis on water as vehicle for the propagation of microbes. Inspired by the great work of Louis Pasteur, who had developed the germ theory of disease, four years later he went to Paris to specialize in bacteriology at the Pasteur Institute, which gathered the great names of this branch of science of that time. He was financed by his